Rapid Micro Biosystems, Inc. Deferred Income Tax Expense (Benefit)
Rapid Micro Biosystems, Inc. (RPID) reported Deferred Income Tax Expense (Benefit) of $11.42 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-12
- Rapid Micro Biosystems, Inc. deferred income tax expense (benefit) for fiscal 2025 was $11.42M, a 0.62% decline from fiscal 2024.
- Rapid Micro Biosystems, Inc. deferred income tax expense (benefit) for fiscal 2024 was $11.49M, a 7.44% decline from fiscal 2023.
- Rapid Micro Biosystems, Inc. deferred income tax expense (benefit) for fiscal 2023 was $12.42M.
- Rapid Micro Biosystems, Inc. deferred income tax expense (benefit) for fiscal 2022 was -$16.17M, a 180.77% decline from fiscal 2021.
| Period end | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $11.42M 10-K · filed 2026-03-12 | |
| 2024-12-31 | $11.49M 10-K · filed 2026-03-12 | |
| 2023-12-31 | $12.42M 10-K · filed 2025-02-28 | -$12.42M 10-K · filed 2024-03-01 |
| 2022-12-31 | -$16.17M 10-K · filed 2024-03-01 | |
| 2021-12-31 | $20.02M 10-K · filed 2023-03-10 | |
| 2020-12-31 | -$7.74M 10-K · filed 2022-03-24 |